Elite Pharmaceuticals appoints CFO
Robert Chen, who succeeds Marc Bregman, has an extensive and diversified financial leadership background in the areas of financial reporting, including manufacturing, financial and cost accounting, SEC, GAAP, and IFRS, as well as financial planning and analysis.